Cogent Biosciences Stock Options

COGT Stock  USD 9.47  0.04  0.42%   

Cogent Biosciences Market Cap Over Time

   Market Cap   
       Timeline  

Cogent Total Stockholder Equity

Total Stockholder Equity

156.07 Million

At this time, Cogent Biosciences' Total Stockholder Equity is comparatively stable compared to the past year.

Cogent Biosciences Corporate Management

Rachael MDVP DevelopmentProfile
Sara SaltzmanVP AffairsProfile
Jessica MDChief OfficerProfile
Brad FellSenior ChemistryProfile
Christi WaarichSenior RelationsProfile
Brad BarnettChief OfficerProfile

Additional Tools for Cogent Stock Analysis

When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.